Overview

Testosterone Treatment for Hypogonadal Men

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Demonstrate efficacy and safety of Testosterone Gel 1.62% for the treatment of hypogonadal men
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate